Form 4: Vertex Pharmaceuticals Executive Amit Sachdev Reports Stock Sale
SEC Form 4 Filing
Amit Sachdev, EVP Chief Patient & External Affairs Officer at Vertex Pharmaceuticals, reports selling 32 shares of common stock at $430.93 per share.
Summary
- On May 15, 2024, Amit Sachdev, EVP Chief Patient & External Affairs Officer at Vertex Pharmaceuticals, sold 32 shares of common stock.
- The sale was executed at a price of $430.93 per share.
- Following the transaction, Sachdev directly owns 55,325 shares of Vertex Pharmaceuticals common stock.
- Sachdev also indirectly owns 6,565 shares held in trust and 882 shares in a 401(k).
- The transaction was made pursuant to a company-approved trading plan under Rule 10b5-1, which was entered into on May 9, 2023.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing a stock sale by an executive. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider trading activity. It provides transparency into the transactions of company executives and their holdings in the company's stock.
Stakeholder Impact
- The stock sale by a company executive may have a minor impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 05/09/2023 | Date of entry into Rule 10b5-1 trading plan |
| 05/15/2024 | Date of stock sale transaction |
| 05/17/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.